Patents by Inventor Emilie Tonglet

Emilie Tonglet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising silicones and two solubilized active principles
    Patent number: 7901698
    Abstract: Topically applicable, anhydrous and physically/chemically stable pharmaceutical compositions useful for the treatment of disorders of the skin, notably psoriasis, contain a silicone agent; a therapeutically effect amount of a compound A, which is vitamin D or derivative thereof, solubilized in a solvent therefor; and a therapeutically effective amount of a compound B, which is the corticosteroids, also solubilized in a solvent therefor.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: March 8, 2011
    Assignee: Galderma S.A.
    Inventors: Leslie Zanutto, Sandrine Orsoni, Claire Mallard, Emilie Tonglet
  • Pharmaceutical compositions comprising organopolysiloxane elastomers and solubilized bioactive compounds
    Publication number: 20080194528
    Abstract: Stable, anhydrous pharmaceutical compositions contain an organopolysiloxane elastomer and, as bioactive ingredient, at least one vitamin D compound in a solubilized form, and are useful for the topical treatment of psoriasis and other skin disorders/afflictions.
    Type: Application
    Filed: December 17, 2007
    Publication date: August 14, 2008
    Applicant: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Nathalie Barthez, Emilie Tonglet, Sandrine Orsoni, Laurent Fredon
  • Pharmaceutical compositions comprising silicones and two solubilized active principles
    Publication number: 20050282788
    Abstract: Topically applicable, anhydrous and physically/chemically stable pharmaceutical compositions useful for the treatment of disorders of the skin, notably psoriasis, contain a silicone agent; a therapeutically effect amount of a compound A selected from the group consisting of vitamin D or derivative thereof, solubilized in a solvent therefor; and a therapeutically effective amount of a compound B selected from the group consisting of the corticosteroids, also solubilized in a solvent therefor.
    Type: Application
    Filed: September 29, 2004
    Publication date: December 22, 2005
    Inventors: Leslie Zanutto, Sandrine Orsoni, Claire Mallard, Emilie Tonglet